Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00150059
Status:
COMPLETED
Last Update Posted:
2008-02-15
First Post:
2005-09-07
Brief Title:
Efficacy and Safety of Pimecrolimus Cream 1 in Patients 3 Months of Age With Mild or Moderate Atopic Dermatitis
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2008-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the efficacy and safety of pimecrolimus cream 1 in its registered indication treatment of patients 3 months of age with mild to moderate atopic dermatitis
This study is not enrolling patients in the United States
This study is not enrolling patients in the United States
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None